The Department of the Army Medical Command awarded a $1 million blanket purchase agreement to Pharmalucence, Inc. to provide various radiopharmaceuticals to military treatment facilities. No set-aside was designated for this single award contract, which has a period of performance from October 1, 2020 through September 30, 2025. Three task orders were subsequently awarded against this blanket purchase agreement by the Defense Health Agency to procure radiopharmaceuticals and related supplies...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA), Network Contracting Office 1 (NCO 1) to Palisade-Heritage Joint Venture II, LLC, a service-disabled veteran-owned small business (SDVOSB). The BPA has a 5-year period of performance and a ceiling value of $3,000,000 to provide first fill (emergency) prescription fulfillment services to VA medical facilities in VISN 1, which covers the Northeastern and Southeastern regions. The contractor will fill...
The Defense Health Agency awarded a blanket purchase agreement to The Compounding Center Inc. to provide various pharmaceutical supplies and compounded medications. Under four firm fixed price call contracts valued between $25,000 to $150,000 placed against the agreement, the contractor will deliver shortage pharmaceuticals, compounded drugs, and chemical compounds to Walter Reed National Military Medical Center in Bethesda, Maryland. Performance is scheduled to take place through various...
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals, to provide metformin HCL tablets. The contract has a potential value of $30,829,723.75 and a period of performance from July 1, 2020 to June 30, 2025. The contract covers the supply of various metformin tablet strengths to support the VA, Department of Defense, Bureau of Prisons, and...
Golden State Medical Supply, Inc. was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs National Acquisition Center to provide pharmaceutical products. The contract facilitates orders for prazusrel hydrochloride 5mg and 10mg tablets to VA hospitals and facilities through February 2025. With a potential value of $3,892,430.05, the contract leverages Golden State Medical Supply's distribution network to deliver specified medications on an as-needed basis...
The Department of Veterans Affairs (VA) National Acquisition Center has awarded an Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc. for the procurement of Metformin HCL SA Tablets. The $71,077,076.15 contract has a base period of one year with four additional one-year option periods, and will serve multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract consists of two...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc. to provide Metolazone tablets to the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service (IHS). The single-award contract has a ceiling value of $3,413,993.75 and a period of performance from August 24, 2021 to August 23, 2022, with four one-year option periods. The contract facilitates the provision of Metolazone 5mg,...
The key products and services being delivered under this federal contract IDV award are Perphenazine tablets in four different dosage strengths (2mg, 4mg, 8mg, and 16mg). The contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. This single-award, indefinite delivery contract has a ceiling value of $1,260,190.52 and a period of...
The federal contract IDV award was issued by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc. for the provision of APAP 325mg/Butalbital 50mg/Caffeine 40mg tablets. This single-award indefinite delivery contract has a ceiling value of $1,970,469.00 and a period of performance from January 21, 2023 to January 20, 2025, with four one-year option periods. The contract aims to provide an uninterrupted supply of the specified pharmaceutical...
The Department of Veterans Affairs National Acquisition Center awarded Golden State Medical Supply, Inc. a single-award, indefinite delivery contract with a potential value of $14,138,686 to supply oxcarbazepine tablets. The contract's period of performance is one base year from October 7, 2019 through October 6, 2020, with four one-year option periods extending to October 6, 2024. Under the contract, Golden State Medical Supply will provide oxcarbazepine tablets in 150mg, 300mg, and 600mg...